A new homoleptic Cu(I) photosensitizer, [Cu(dsbtmp)2](+) (dsbtmp = 2,9-di(sec-butyl)-3,4,7,8-tetramethyl-1,10-phenanthroline), designed to exhibit cooperative steric hindrance, unexpectedly produced strong photoluminescence (Φ = 1.9-6.3%) and long excited state lifetimes (τ = 1.2-2.8 μs) in a broad range of coordinating and noncoordinating solvents. The combination of the 2,9-sec-butyl substituents with the neighboring 3,8-methyl groups led to a Cu(I) complex with small degrees of ground and excited state distortion ultimately producing a molecule with robust metal-to-ligand charge transfer photophysics largely insulated from solvent interactions, reversible redox chemistry serving as a strong excited state reductant, along with impressive thermodynamic and photochemical stability in solution.
No takes yet. Share an insight, caveat, or question.
McCusker et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: